Medifast (MED) Tops Q3 EPS by 43c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
Tweet
Share
E-mail
Get Alerts MED Hot Sheet
Price: $12.11 +2.02%
Financial Fact:
Nonoperating Income (Expense), Total: 58K
Today's EPS Names:
JBLU, SICP, OMID, More
Financial Fact:
Nonoperating Income (Expense), Total: 58K
Today's EPS Names:
JBLU, SICP, OMID, More
Join SI Premium – FREE
Medifast (NYSE: MED) reported Q3 EPS of ($0.19), $0.43 better than the analyst estimate of ($0.62). Revenue for the quarter came in at $72.05 million versus the consensus estimate of $67.7 million.
For earnings history and earnings-related data on Medifast (MED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JetBlue Airways (JBLU) Misses Q3 EPS by 6c, Misses on Revenue
- Noble Corp (NE) Misses Q3 EPS by 81c; Offers Outlook
- JetBlue shares jump on Q3 results and 2027 outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
